Jessica Lynn Fewkes, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mohs Surgery | 4 | 2013 | 217 | 0.400 |
Why?
|
| Carcinoma, Basal Cell | 3 | 2013 | 565 | 0.330 |
Why?
|
| Skin Aging | 1 | 2022 | 140 | 0.180 |
Why?
|
| Facial Neoplasms | 3 | 2013 | 126 | 0.160 |
Why?
|
| Head and Neck Neoplasms | 1 | 2013 | 2930 | 0.150 |
Why?
|
| Skin Physiological Phenomena | 1 | 1995 | 193 | 0.110 |
Why?
|
| Bandages | 1 | 1993 | 271 | 0.100 |
Why?
|
| Nose Neoplasms | 1 | 2013 | 250 | 0.090 |
Why?
|
| Skin Neoplasms | 6 | 2022 | 5859 | 0.080 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 1993 | 452 | 0.080 |
Why?
|
| Lentigo | 1 | 2004 | 37 | 0.060 |
Why?
|
| Patient Participation | 1 | 1993 | 1444 | 0.060 |
Why?
|
| Facial Dermatoses | 1 | 2004 | 87 | 0.060 |
Why?
|
| Wound Healing | 1 | 1995 | 2800 | 0.050 |
Why?
|
| Precancerous Conditions | 2 | 2004 | 980 | 0.050 |
Why?
|
| Skin, Artificial | 1 | 1999 | 89 | 0.040 |
Why?
|
| Face | 1 | 2022 | 1029 | 0.030 |
Why?
|
| Granulation Tissue | 1 | 1995 | 92 | 0.030 |
Why?
|
| Protoporphyrins | 1 | 1995 | 167 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 9410 | 0.030 |
Why?
|
| Resins, Plant | 1 | 1993 | 20 | 0.030 |
Why?
|
| Aminolevulinic Acid | 1 | 1995 | 147 | 0.030 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1995 | 360 | 0.030 |
Why?
|
| Wound Infection | 1 | 1995 | 244 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2013 | 59548 | 0.020 |
Why?
|
| Melanoma | 2 | 2004 | 5702 | 0.020 |
Why?
|
| Plant Extracts | 1 | 1993 | 496 | 0.020 |
Why?
|
| Dermatologic Agents | 1 | 1993 | 314 | 0.020 |
Why?
|
| Disease | 1 | 1995 | 675 | 0.020 |
Why?
|
| Cicatrix | 1 | 1995 | 798 | 0.020 |
Why?
|
| Photochemotherapy | 1 | 1995 | 828 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 1995 | 1873 | 0.020 |
Why?
|
| Warfarin | 1 | 1996 | 1493 | 0.020 |
Why?
|
| Cell Division | 1 | 1995 | 4473 | 0.020 |
Why?
|
| Skin | 2 | 1995 | 4499 | 0.020 |
Why?
|
| Postoperative Care | 1 | 1993 | 1480 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2013 | 81659 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1996 | 2270 | 0.020 |
Why?
|
| Keratins | 1 | 1986 | 499 | 0.010 |
Why?
|
| Aged | 5 | 2013 | 171319 | 0.010 |
Why?
|
| Aspirin | 1 | 1996 | 3135 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1995 | 3464 | 0.010 |
Why?
|
| Humans | 11 | 2022 | 767040 | 0.010 |
Why?
|
| Adult | 3 | 2013 | 223317 | 0.010 |
Why?
|
| Middle Aged | 2 | 2013 | 223233 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 2004 | 1097 | 0.010 |
Why?
|
| Female | 6 | 2013 | 396660 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2004 | 1472 | 0.010 |
Why?
|
| Male | 4 | 2013 | 364203 | 0.010 |
Why?
|
| Skin Pigmentation | 1 | 1999 | 280 | 0.010 |
Why?
|
| Inflammation | 1 | 1995 | 10869 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2004 | 2843 | 0.010 |
Why?
|
| Keratinocytes | 1 | 1999 | 876 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1996 | 15824 | 0.010 |
Why?
|
| Cattle | 1 | 1999 | 3813 | 0.010 |
Why?
|
| Administration, Cutaneous | 1 | 1995 | 715 | 0.010 |
Why?
|
| Postoperative Hemorrhage | 1 | 1996 | 418 | 0.010 |
Why?
|
| Hematoma | 1 | 1996 | 766 | 0.010 |
Why?
|
| Antibodies | 1 | 1999 | 2419 | 0.010 |
Why?
|
| Collagen | 1 | 1999 | 2636 | 0.010 |
Why?
|
| Reoperation | 1 | 1999 | 4325 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1999 | 4167 | 0.000 |
Why?
|
| Microscopy, Fluorescence | 1 | 1995 | 2628 | 0.000 |
Why?
|
| Keratoacanthoma | 1 | 1986 | 33 | 0.000 |
Why?
|
| Graft Rejection | 1 | 1999 | 4498 | 0.000 |
Why?
|
| Hydrolases | 1 | 1986 | 146 | 0.000 |
Why?
|
| Intermediate Filament Proteins | 1 | 1986 | 261 | 0.000 |
Why?
|
| Time Factors | 1 | 2004 | 40154 | 0.000 |
Why?
|
| Protein Precursors | 1 | 1986 | 1134 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1986 | 2472 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1999 | 54886 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 1999 | 65295 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1986 | 4049 | 0.000 |
Why?
|
| Adolescent | 1 | 1996 | 89046 | 0.000 |
Why?
|
| Animals | 1 | 1999 | 168965 | 0.000 |
Why?
|